IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Cevec Launches New Technology

5:24 AM MDT | March 23, 2009

Biopharmaceutical company Cevec Pharmaceuticals (Cologne) says it has launched Cevec Amniocyte Production Technology (CAP-T), a transient expression system for fast, serum-free, high-yield protein production. CAP-T technology aims to meet growing demand for an integrated platform for transient production of complex biologics. The technology allows customers to proceed from gene to milligram and gram amounts of protein within two weeks, Cevec says. The fast process times, high yields, and human post-translational modifications, especially with complex and highly...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa